Willemijn van der Wulp (W van der Wulp)

Years Active: 2023-2024
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Willemijn van der Wulp, W Luu, M E Ressing, J Schuurman, S I van Kasteren, L Guelen, R C Hoeben, B Bleijlevens, M H M Heemskerk
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces. mAbs 16 (1) (2024)
Willemijn van der Wulp, W Luu, M E Ressing, J Schuurman, S I van Kasteren, L Guelen, R C Hoeben, B Bleijlevens, M H M Heemskerk
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces. mAbs 16 (1) (2024)
Willemijn van der Wulp, W Luu, M E Ressing, J Schuurman, S I van Kasteren, L Guelen, R C Hoeben, B Bleijlevens, M H M Heemskerk
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces. mAbs 16 (1) (2024)
Willemijn van der Wulp, W Luu, M E Ressing, J Schuurman, S I van Kasteren, L Guelen, R C Hoeben, B Bleijlevens, M H M Heemskerk
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces. mAbs 16 (1) (2024)
Willemijn van der Wulp, Dennis F G Remst, Michel G D Kester, Renate S Hagedoorn, Paul W H I Parren, Sander I van Kasteren, Janine Schuurman, Wytske M van Weerden, Maaike E Ressing, Boris Bleijlevens, Mirjam H M Heemskerk
Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8 + T-cell immunity towards cancer cells. Cancer gene therapy (2023)

Willemijn van der Wulp.css-eqlu8i{font-size:small;padding-left:4px;} (W van der Wulp)